Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
47
GENI Quote, Financials, Valuation and Earnings
Last price:
$10.78
Seasonality move
:
1.92%
Day range:
$10.67 - $10.95
52-week range:
$8.15 - $13.73
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.40x
P/B ratio:
3.56x
Volume:
1M
Avg. volume:
5.7M
1-year change:
23.51%
Market cap:
$2.6B
Revenue:
$510.9M
EPS (TTM):
-$0.48
Analysts' Opinion
-
Consensus RatingGenius Sports Ltd. has received a consensus rating of Buy. The company's average rating is a Buy based on 15 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $15.53, Genius Sports Ltd. has an estimated upside of 44.16% from its current price of $10.77.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $12.00 representing 100% downside risk from its current price of $10.77.
Fair Value
-
According to the consensus of 17 analysts, Genius Sports Ltd. has 44.16% upside to fair value with a price target of $15.53 per share.
GENI vs. S&P 500
-
Over the past 5 trading days, Genius Sports Ltd. has underperformed the S&P 500 by -0.58% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Genius Sports Ltd. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Genius Sports Ltd. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Genius Sports Ltd. reported revenues of $166.3M.
Earnings Growth
-
Genius Sports Ltd. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Genius Sports Ltd. reported earnings per share of -$0.11.
Enterprise value:
2.4B
EV / Invested capital:
3.18x
Price / LTM sales:
4.40x
EV / EBIT:
--
EV / Revenue:
3.96x
PEG ratio (5yr expected):
-0.45x
EV / Free cash flow:
67.39x
Price / Operating cash flow:
74.98x
Enterprise value / EBITDA:
108.46x
Gross Profit (TTM):
$130.9M
Return On Assets:
-13.54%
Net Income Margin (TTM):
-19.71%
Return On Equity:
-18.16%
Return On Invested Capital:
-17.67%
Operating Margin:
-8.02%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $391.1M | $462.5M | $604.5M | $120.2M | $166.3M | |
| Gross Profit | $60.7M | $90.6M | $130.9M | $39.7M | $41M | |
| Operating Income | -$66.4M | -$76.4M | -$103.3M | -$2.3M | -$13.3M | |
| EBITDA | $6.6M | $6.6M | $22.1M | $13.3M | $5.8M | |
| Diluted EPS | -$0.86 | -$0.32 | -$0.48 | $0.05 | -$0.11 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $333.9M | $238.1M | $248.1M | $224.4M | $465.2M | |
| Total Assets | $896.9M | $734M | $772.2M | $724.9M | $1B | |
| Current Liabilities | $146.3M | $140.3M | $174.7M | $149.1M | $269.3M | |
| Total Liabilities | $184.8M | $161.1M | $194.8M | $169.6M | $326.6M | |
| Total Equity | $712.1M | $572.9M | $577.4M | $555.3M | $722.5M | |
| Total Debt | $95K | $14M | $11.5M | $4.9M | $26.1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$7.5M | $19.3M | $84.1M | -$3.6M | $27.2M | |
| Cash From Investing | -$45.8M | -$59.4M | -$90.3M | -$19.1M | -$38.7M | |
| Cash From Financing | -$612K | -$7.6M | $144M | -$7K | -$6K | |
| Free Cash Flow | -$34.1M | -$14.5M | $35.5M | $15.4M | $3.3M | |
GENI
Sector
Market Cap
$2.6B
$324.3M
Price % of 52-Week High
78.44%
73.3%
Dividend Yield
0%
0%
Shareholder Yield
-5.03%
1.97%
1-Year Price Total Return
23.51%
-3.66%
Beta (5-Year)
1.921
0.537
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$10.75
200-day SMA
Sell
Level
$10.90
Bollinger Bands (100)
Sell
Level
10.46 - 12.8
Chaikin Money Flow
Sell
Level
-88.2M
20-day SMA
Buy
Level
$10.69
Relative Strength Index (RSI14)
Buy
Level
52.95
ADX Line
Buy
Level
20.25
Williams %R
Neutral
Level
-71.6763
50-day SMA
Buy
Level
$10.72
MACD (12, 26)
Buy
Level
0.09
25-day Aroon Oscillator
Buy
Level
28
On Balance Volume
Sell
Level
-19M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.6348)
Buy
CA Score
(Annual)
Level (0.5289)
Buy
Beneish M-Score
(Annual)
Level (-3.5102)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.3752)
Buy
Piotroski F Score
(Annual)
Level (8)
Sell
Quality Ratio Score
Level (6)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Genius Sports Ltd. engages in the provision of scalable, technology-led products and services to the sports, sports betting, and sports media industries. It also involves in Sports League, which offers technology infrastructure for the collection, integration, and distribution of live data; Sportsbooks, which includes collection of live sports data, odds making, risk management and player marketing; and Sports Media, which provides a range of online marketing and fan engagement tools. The company was founded by Mark Adrian Locke in 2000 and is headquartered in London, United Kingdom.
Stock Forecast FAQ
In the current month, GENI has received 15 Buy ratings 2 Hold ratings, and 0 Sell ratings. The GENI average analyst price target in the past 3 months is $15.53.
-
Where Will Genius Sports Ltd. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Genius Sports Ltd. share price will rise to $15.53 per share over the next 12 months.
-
What Do Analysts Say About Genius Sports Ltd.?
Analysts are divided on their view about Genius Sports Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Genius Sports Ltd. is a Sell and believe this share price will drop from its current level to $12.00.
-
What Is Genius Sports Ltd.'s Price Target?
The price target for Genius Sports Ltd. over the next 1-year time period is forecast to be $15.53 according to 17 Wall Street analysts, 15 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is GENI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Genius Sports Ltd. is a Buy. 15 of 17 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of GENI?
You can purchase shares of Genius Sports Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Genius Sports Ltd. shares.
-
What Is The Genius Sports Ltd. Share Price Today?
Genius Sports Ltd. was last trading at $10.78 per share. This represents the most recent stock quote for Genius Sports Ltd.. Yesterday, Genius Sports Ltd. closed at $10.77 per share.
-
How To Buy Genius Sports Ltd. Stock Online?
In order to purchase Genius Sports Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get GENI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GENI
Sector
P/E ratio
--
17.37x
PEG ratio
-0.45x
0.11x
P/B ratio
3.56x
1.33x
Price / LTM sales
4.40x
0.57x
Growth Metrics
GENI
Sector
Revenue growth
38.34%
3.54%
Earnings growth
-308.97%
--
Revenue (5-year growth)
34.84%
3.17%
Earnings forecast
$0.07
$0.25
Profitability
GENI
Sector
Profitability FY 2024
$127.4M
$298.2M
Return on invested capital
-17.67%
3.4%
Return on assets
-13.54%
2.25%
Return on equity
-18.16%
5.88%
Earnings Date
Last Earnings Date
Nov
4
Next Earnings Date
Mar
3
Estimated Next Earnings Date
Feb
3
Balance Sheet
GENI
Sector
Total cash
$207.8M
$130M
Short term investments
--
$41M
Total assets
$792.3M
$1.1B
Long term debt
$26.1M
$36M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
85
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
63
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
